The Edward Harkness Eye Institute at NewYork-Presbyterian/
Illuminating a Novel Approach to Idiopathic Intracranial Hypertension: Venous Sinus Stenting
Weill Cornell Medicine physicians conducted a meta-analysis of outcomes data for venous sinus stenting that confirms it is viable treatment option for medically refractory IIH patients.
New Era of Precision Medicine in Ophthalmology: A Novel Algorithm Sharpens the Decision-making Process for Treating Macular Edema
Columbia physicians develop a unique algorithm for macular edema that predicts the behavior of intraretinal fluid over time, providing valuable insights into the dynamics of retinal tissue under varying hydration conditions.
NYC-SIGHT: Facilitating Eye Health Screenings and follow-up Care in Vulnerable Populations
Columbia ophthalmology faculty present baseline results of an innovative strategy to facilitate eye health screenings and follow-up eye care in underserved communities.
Shining a Light on 3D Digital Surgical Visualization
A Weill Cornell Medicine corneal transplant specialist compares 3D digital visualization technology to the traditional analog surgical visualization approach in regard to coaxial light intensity and rate of postoperative visual recovery.
Dry AMD: A Decade-Long Pathway to a Promising Therapeutic
Columbia ophthalmic scientist identifies a first-in-class treatment that inhibits lipofuscin accumulation in the retina and may promote photoreceptor survival in patients with atrophic age-related macular degeneration and other forms of macular dystrophy.
Harnessing Cytotoxic T-Cells to Combat Cytomegalovirus Retinitis
A Weill Cornell Medicine vitreoretinal specialist reports on the first application of T-cell therapy for ocular disease.
Optical Coherence Tomography: A Paradigm Shift in Diagnosing Glaucoma
Columbia ophthalmologists propose using an OCT-based approach to provide a more accurate and standardized method for detecting glaucoma without the need for perimetry.
Pre-Clinical Model May Enable Development of New Treatments for Dry AMD
Weill Cornell Medicine researchers genetically engineered a pre-clinical model of dry age-related macular degeneration that may lead to the development of a new treatment target.
Is There a Role for Nutrient Supplements in Glaucoma Management?
In a phase 2 clinical trial, Columbia ophthalmology researchers administer vitamin B3 and pyruvate to patients with glaucoma and moderate visual field loss, observing significant improvements in visual function over several months.
Major Grant Supports Research into Proliferative Vitreoretinopathy
Weill Cornell Medicine faculty pursue new antibodies to treat this potentially blinding disease.
Leading a National Program to Highlight Ocular Trauma
Columbia ophthalmologist spearheads efforts to develop national guidelines, proficiency standards, and educational programs.
Residency Program at NewYork-Presbyterian Queens
The NewYork-Presbyterian/Weill Cornell Medical Center Ophthalmology Residency Program fosters the development of outstanding clinicians and surgeons who possess the skills necessary to expertly diagnosis and manage the full spectrum of ophthalmic disease.
Residency Program at NYC Health + Hospitals/Harlem
Through the collaboration with NYC Health + Hospitals/Harlem, ophthalmology residents broaden their experience with exposure to a different hospital system, a wide variety of patients and ocular disease, and a more severe spectrum of disease.
Breaking Barriers to Eye Care in Underserved Communities
Driven by a commitment to providing equal access to eye care, NewYork-Presbyterian’s ophthalmology residents are providing comprehensive eye care in Central Harlem, Queens, and at community outreach clinics throughout NYC.
Community-Based Initiatives in Vision Care
Our residents take part in community-based initiatives to provide screenings at public housing developments and collaborate with programs to provide care to uninsured or underinsured individuals and families.
New COVID-era Eye Care Paradigms
As front-line healthcare workers continue to battle the pandemic, the Department of Ophthalmology at NewYork-Presbyterian/Columbia University Irving Medical Center is developing new COVID-era eye care paradigms to meet the challenges facing clinicians and patients.
Columbia Ophthalmology Residency - Innovation and New Opportunities
Since mid-March, the ophthalmology residency program at NewYork-Presbyterian/Columbia University Irving Medical Center has shared dozens of lectures, accessible to trainees across the enterprise and throughout the country.
Surmounting Challenges and Seizing Opportunities of the COVID-19 Pandemic
With mounting concern that ophthalmologists may be at higher risk of infection, NewYork-Presbyterian’s ophthalmologists are creating new paradigms of care to protect physicians and staff while restoring eyesight and quality of life to our patients.
Advancing the Boundaries of Innovation in Ophthalmic Surgery
Harnessing decades of clinical experience and the latest developments in cutting-edge surgical technology, the Ophthalmology program at NewYork-Presbyterian/Weill Cornell Medical Center is advancing the boundaries of innovation in the treatment of complex eye disorders.
Spotlight on Ophthalmic Surgery Innovations
Innovations include: K-Pro for Corneal Repair, Stereoscopic 3D “Heads Up” Digital Visualization System, Amniotic Membrane Application for Severe Ocular Surface Disease, OculoPlastics Expertise for Transorbital Neurosurgery, & PROSE for Complex Corneal Disease.
Realizing the Vision of Precision Ophthalmology™
After decades of pioneering research and clinical achievements, we are making groundbreaking advances in Precision Ophthalmology™. Defined as customized genetic, diagnostic, and translational clinical care, Precision Ophthalmology™ uses a patients’ genetic profile to tailor treatment designed for them.
Strength in Collaboration: Columbia and Weill Cornell Ophthalmology at NYP
Columbia and Weill Cornell ophthalmologists propelled the transformative growth of the Ophthalmology services at NewYork-Presbyterian by providing advanced treatment for eye diseases and unmatched research and educational opportunities for the leaders of tomorrow.
Glaucoma and Genetics Come Into Focus
Dr. John shares his groundbreaking research on the molecular basis of glaucoma, uniting engineering and technology with molecular, genetic, and physiologic methods to identify the genes and molecular mechanisms underlying this neurodegenerative disease.
Elevating Precision and Safety in Cataract Surgery
With the addition of femtosecond laser for cataract extraction and two innovative optical systems for measuring the refractive power of the eye during surgery itself, NewYork-Presbyterian/Weill Cornell Medical Center is able to offer patients visual results that have been documented to exceed national averages.
Fulfilling a Vision for Superior Ophthalmic Care
The partnership between NewYork-Presbyterian and Weill Cornell Medicine has propelled the growth of the Department of Ophthalmology at NewYork-Presbyterian/Weill Cornell Medical Center, which is transforming ophthalmic surgery with our focus on advanced technology and extraordinary facilities.
Precision Ophthalmology 2020
A leading international center for the management of sight-threatening disorders, the Department of Ophthalmology at Columbia University Irving Medical Center is continuing the tradition of innovation with Precision Ophthalmology™ 2020.
Glaucoma: Accelerating Genetic Discoveries for Clinical Applications
With the support of a major award from The Brown Foundation, Dr. Jeffrey M. Liebmann and his team have launched the Brown Glaucoma Genetics Initiative, a continuum of investigative and therapeutic projects with the aim of developing treatments for specific subtypes of the disease.
Newsletters for Medical Professionals
2022 Issue 2
2021 Issue 2
2021 Issue 1
- The Rarefied World of Ocular Oncology
- Retinal Detachment: Improving Outcomes with Technique and Technology
- On the Move to Prevent Blindness
- Ophthalmology Residency Program: Transforming Eye Care in an Underserved Community
- Pediatric Cataracts: Management Challenges and Treatment Approaches